相关实验视频
Updated: May 15, 2025

08:30
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
21.6K
产生氨酸的CD39+等离子体对在儿科IBD中成功治疗infliximab有倾向
Alexander Schnell1, Benedikt Schwarz2, Hannah Schmidt3
1Pediatric Gastroenterology and Hepatology, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany alexander.schnell@uk-erlangen.de.
Life science alliance
|April 8, 2025
概括
在B细胞上的CD39和CD73调节免疫反应. 在儿科炎症性肠病 (IBD) 中,B细胞的CD39表达增加与成功的因弗力西马布 (IFX) 治疗相关,这表明治疗生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- B细胞产生互白素-10并表达CD39和CD73核突酶.
- CD39和CD73将细胞外ATP (eATP) 代谢产生免疫抑制性腺,影响免疫平衡.
- 了解B细胞免疫调节分子表达在儿科炎性肠病 (IBD) 中至关重要.
研究的目的:
- 研究儿科IBD患者B细胞子集上的CD39和CD73的表达.
- 为了确定CD39/CD73表达和对因弗利克西马布 (IFX) 治疗的反应之间的关联.
- 探索这些分子作为IFX治疗成功的潜在生物标志物的作用.
主要方法:
- 流细胞测量用于分析B细胞子集和CD39/CD73表达在42名儿科IBD患者和14名健康对照 (HC) 中.
- 在治疗12个月后评估IFX反应.
- 测量了B细胞的ATP降解能力和腺生产.
主要成果:
- 与非响应者 (NRS) 相比,响应的患者 (RS) 在血细胞上增加了CD39和CD39/CD73在原始和记忆B细胞上的共同表达.
- 响应者在治疗前表现出更高的B细胞ATP降解和腺生产.
- IFX不响应者具有较少的α4β7hi血芽细胞,CD39+血芽细胞在炎症组织中减少,特别是在NRS中.
结论:
- 在B细胞,特别是CD39+等离子体上,CD39和CD73的表达可能作为儿童IBDIFX治疗成功的预测生物标志物.
- 这些B细胞子集在IBD免疫治疗的背景下具有调节潜力.
- 向或监测CD39/CD73表达B细胞可以为治疗策略提供信息.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Adrenergic Receptors: ɑ Subtype
1.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.3K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K

